Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
01-2018 | 10-2017 | 07-2017 | 04-2017 | 01-2017 | |
Operating Expenses | 782 | 516 | 876 | 881 | 332 |
Operating Income | -782 | -516 | -876 | -881 | -332 |
Interest Expense | 0 | 0 | 0 | -1 | 0 |
Other Income | 10 | 3 | -19 | -3 | 21 |
Pre-tax Income | -772 | -513 | -895 | -882 | -311 |
Net Income Continuous | -772 | -513 | -895 | -882 | -311 |
Net Income | $-772 | $-513 | $-895 | $-882 | $-311 |
EPS Basic Total Ops | -2.40 | -2.42 | -4.55 | -4.55 | -2.27 |
EPS Basic Continuous Ops | -2.08 | -1.40 | 5.12 | -2.60 | -0.94 |
EPS Diluted Total Ops | -2.40 | -2.42 | -4.55 | -4.55 | -2.27 |
EPS Diluted Continuous Ops | -2.08 | -1.40 | 5.12 | -2.60 | -0.94 |
EBITDA(a) | $-782 | $-516 | $-876 | $-880 | $-332 |